Overview

Clot Dissolving Treatment for Blood Clots in the Lungs

Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if tenecteplase plus enoxaparin is safe and effective in the treatment of patients with severe submassive pulmonary embolism.
Phase:
Phase 3
Details
Lead Sponsor:
Jeffrey Kline
Treatments:
Enoxaparin
Enoxaparin sodium
Tenecteplase
Tissue Plasminogen Activator